Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer

被引：1

作者：

Abouharb, Sausan ^{[1
]}

Corn, Paul G. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Unit 1374, Houston, TX 77030 USA

来源：

CURRENT ONCOLOGY REPORTS | 2013年 / 15卷 / 03期

关键词：

Metastatic; Prostate cancer; Castration-resistant; Optimal sequencing; Individualized therapy; PHASE-II; INCREASED SURVIVAL; ANDROGEN ABLATION; CLINICAL-TRIAL; ABIRATERONE; IMMUNOTHERAPY; DOCETAXEL; CHEMOTHERAPY; BIOLOGY;

D O I：

10.1007/s11912-013-0311-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prostate cancer is the most common cancer in men worldwide, accounting for approximately 242,000 new cases and 28,000 deaths annually in the USA. Although localized disease is often curable, advanced disease is generally not, especially when the cancer becomes castration-resistant and metastasizes to bone. Fortunately, advances in research have led to the recent approval of several novel therapies for the treatment of metastatic disease, and many other promising agents are in development. With this success arises the distinct challenge of optimizing both sequencing and the design of rational combinations with these agents. This review focuses on practical and experimental approaches to this challenge.

引用

收藏

页码：217 / 223

页数：7

相关论文

共 37 条

[21] The APL Paradigm and the "Co-Clinical Trial" Project [J].

Nardella, Caterina ;

Lunardi, Andrea ;

Patnaik, Akash ;

Cantley, Lewis C. ;

Pandolfi, Pier Paolo .

CANCER DISCOVERY, 2011, 1 (02) :108-116

[22] Endpoints for assessing drug activity in clinical trials [J].

Pazdur, Richard .

ONCOLOGIST, 2008, 13 :19-21

[23] Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy [J].

Ryan, Charles J. ;

Smith, Matthew R. ;

de Bono, Johann S. ;

Molina, Arturo ;

Logothetis, Christopher J. ;

de Souza, Paul ;

Fizazi, Karim ;

Mainwaring, Paul ;

Piulats, Josep M. ;

Ng, Siobhan ;

Carles, Joan ;

Mulders, Peter F. A. ;

Basch, Ethan ;

Small, Eric J. ;

Saad, Fred ;

Schrijvers, Dirk ;

Van Poppel, Hendrik ;

Mukherjee, Som D. ;

Suttmann, Henrik ;

Gerritsen, Winald R. ;

Flaig, Thomas W. ;

George, Daniel J. ;

Yu, Evan Y. ;

Efstathiou, Eleni ;

Pantuck, Allan ;

Winquist, Eric ;

Higano, Celestia S. ;

Taplin, Mary-Ellen ;

Park, Youn ;

Kheoh, Thian ;

Griffin, Thomas ;

Scher, Howard I. ;

Rathkopf, Dana E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02) :138-148

[24] Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy [J].

Ryan, Charles J. ;

Smith, Matthew R. ;

Fong, Lawrence ;

Rosenberg, Jonathan E. ;

Kantoff, Philip ;

Raynaud, Florence ;

Martins, Vanessa ;

Lee, Gloria ;

Kheoh, Thian ;

Kim, Jennifer ;

Molina, Arturo ;

Small, Eric J. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (09) :1481-1488

[25] Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment [J].

Santos Amaral, Teresa Maria ;

Macedo, Daniela ;

Fernandes, Isabel ;

Costa, Luis .

PROSTATE CANCER, 2012, 2012

[26] Contributions of human tumor xenografts to anticancer drug development [J].

Sausville, EA ;

Burger, AM .

CANCER RESEARCH, 2006, 66 (07) :3351-3354

[27] Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis [J].

Scher, HI ;

Sawyers, CL .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) :8253-8261

[28] Clinical states in prostate cancer: Toward a dynamic model of disease progression [J].

Scher, HI ;

Heller, G .

UROLOGY, 2000, 55 (03) :323-327

[29] Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy [J].

Scher, Howard I. ;

Fizazi, Karim ;

Saad, Fred ;

Taplin, Mary-Ellen ;

Sternberg, Cora N. ;

Miller, Kurt ;

de Wit, Ronald ;

Mulders, Peter ;

Chi, Kim N. ;

Shore, Neal D. ;

Armstrong, Andrew J. ;

Flaig, Thomas W. ;

Flechon, Aude ;

Mainwaring, Paul ;

Fleming, Mark ;

Hainsworth, John D. ;

Hirmand, Mohammad ;

Selby, Bryan ;

Seely, Lynn ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (13) :1187-1197

[30] Novel cancer immunotherapy agents with survival benefit: recent successes and next steps [J].

Sharma, Padmanee ;

Wagner, Klaus ;

Wolchok, Jedd D. ;

Allison, James P. .

NATURE REVIEWS CANCER, 2011, 11 (11) :805-812

← 1 2 3 4 →